Current Trends in Mesenchymal Stem Cell Research for Osteosarcoma from 2005 to 2024: A Bibliometric Study
Osteosarcoma (OS) is the most prevalent and aggressive primary bone cancer in children and adolescents and remains a major contributor to cancer-related mortality in this age group. Despite advances in chemotherapy and surgery, survival outcomes have shown limited improvement, particularly in patients with metastatic o...